dr. Arghya Majumder - Nephrologist/Renal Specialist, kolkata

Dr. Arghya Majumder

Nephrologist/Renal SpecialistMBBS, MD - General Medicine, DNB - General Medicine, MRCP (UK)
Experience: 5 yrs
Availability: AMRI Hospital,Dhakuria and 2 others
Book Appointment

Select a hospital/clinic and book an appointment

Fees:   ₹700
Fri Sep 18
Thu Sep 24
Available on Saturday (Sep 19) at AMRI Hospital,Dhakuria.
Timings


SaturdaySep 19 2:00 pm - 4:00 pm
MondaySep 21 2:00 pm - 3:00 pm 4:00 pm - 5:00 pm
TuesdaySep 22 2:00 pm - 3:00 pm
ThursdaySep 24 2:00 pm - 3:00 pm 4:00 pm - 5:00 pm
locationBlock-A, Scheme-L11 P-4&5, Gariahat Rd, Dhakuria, Kolkata, 700029
Location is Not Available

Services

  • Renal Stone Treatment
  • Kidney Stone Disease
  • Kidney Stones
  • Urinary Infections
  • Prostate
  • Kidney Problems
  • Kidney Stone Surgery
  • Diagnostic Nephrology
  • Clinical Nephrology
  • Haemodialysis
  • Peritoneal Dialysis
  • Interventional Nephrology
  • Critical Care Nephrology
  • Paediatric Nephrology
  • Renal Transplantation
  • Qualifications and Recognitions

    Education

  • MBBS
  • MD - General Medicine
  • DNB - General Medicine
  • MRCP (UK)
  • Specializations

  • Nephrologist/Renal Specialist
  • Experience

  • AMRI Hospitals ( Dhakuria & Mukundupur ), Director of Nephrology
  • 2001 - 2011, AMRI, Head Dept. of Nephrology
  • 1998 - 1999, Queen Elizabeth University Hospital, taff Grade Physician/ Clinical Fellow: Nephrology
  • 1996 - 1998, Queen Elizabeth Hospital, Sp Registrar: Nephrology
  • 1994 - 1996, Doncaster Royal Infirmary, Senior House Officer:
  • 1992 - 1993, Kothari Medical Centre, Registrar: General Medicine:
  • 1989 - 1991, NRS Medical College & Hospital , Registrar (Post Graduate Trainee): General Medicine
  • Awards

  • Multiple thesis and audit projects- conducted by my DNB & MPharma students & supervised by me as a guide
  • Microalbuminuria and VEGF A- Diagnostic and prognostic significance- submitted as thesis for PhD in Biochemistry to the Jadavpur University- by my student S. Basu
  • ASCEND study- A randomised, double blind, placebo controlled, parallel group study to assess the effect of the endothelin receptor antagonist avosentan on time to doubling of serum creatinine, end stage renal disease or death in patients with type 2 diabetes mellitus and diabetic nephropathy- A FDA approved international multi- centre study- published in JASN
  • 1998 Higher Speciality training in Nephrology
  • Memberships

  • Member, Indian Society of Nephrology
  • Member, International Society of Nephrology
  • Member, American Society of Nephrology
  • Member, Indian Society of Haemodialysis
  • Member, Indian Society of Peritoneal Dialysis
  • Member, Association of Physician’s of India
  • Member, Royal College of Physicians, UK
  • Member, Indian Medical Association